Chemours’ internal audit has found that three executives, including CEO Mark Newman, violated the company’s ethics code to alter the appearance of cash flow targets dating back to the end of 2022.
Padraig McDonnell has been named as the next CEO of Agilent, as its current leader Mike McMullen prepares to retire.
Looking into weaknesses in internal controls on financial reporting, Chemours has placed top leaders on administrative leave.
Navient's portfolio of student loans has shrunk over the decade, in part due to settlements and offloading federal loan services to other firms.
Prelude Therapeutics, a cancer drug development firm, closed a $25 million share sale Wednesday that will help extend its funding runway.
Edgar "Ed" S. Woolard Jr., the former CEO and chair of DuPont and chair of Apple who led the companies through tremendous change, died Monday.
Ashland is planning to sell its Nutraceuticals business segment and invest in other core segments as its consolidates its portfolio.
MRA Group, the developer behind the Chestnut Run Innovation and Science Park (CRISP), has secured $63 million in financing for the project.
NEWARK – Artesian Resources, the water and wastewater utility company, expects to raise $34.8 million in a new share sale – its first in more than a decade. Artesian supplies […]
Prelude Therapeutics announced Thursday that it’s selling millions of new shares to raise $100 million to support its drug pipeline research.
© 2024 Delaware Business Times